Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial

Authors: Antoní Torres, Nanshan Zhong, Jan Pachl, Jean‐François Timsit, Marin H. Kollef, Zhangjing Chen, Jie Song, Dianna Taylor, Peter J. Laud, Gregory G. Stone, Joseph W. Chow - The Lancet 2017 cited by 443